Skip to main content

Table 2 Sanger and next generation sequencing results

From: Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk

  Sanger sequencing NGS
Samples 100 100
Amplicons (per sample) 370 1969
Bases analyzed (per sample) 88,631 88,631
Total positive bases 3923 3923
•Single base substitutions 3884 3884
•Small indels 39 39
Total negative bases 8,859,177 8,859,177
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us